Sequent Medical: Terumo Makes Big Bet On Aneurysm Embolization With Sequent Acquisition
The $280m-plus acquisition fits with Terumo's strategy to grow its neurovascular device business, which it entered 10 years ago. Terumo will also pay Sequent's owners another $100m based on the achievement of specific development or commercial milestones.
Read full article »
Sequent Medical is engaged in the development of catheter-based devices for neurovascular specialists and their patients.
Read more